REBECCA RUSSO: Open Payments
NPI 1093119216 · BROOKLYN, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$385 in 10 payments from 6 companies in 2025. Trend: 2023 $206 · 2024 $160 · 2025 $385
Food & beverage: $385
| Company | Payments | Amount |
|---|---|---|
| Abbott Laboratories | 1 | $165 |
| Sumitomo Pharma America, Inc. | 4 | $98 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $56 |
| IMMUNITYBIO, INC. | 1 | $27 |
| UROGEN PHARMA, INC. | 1 | $22 |
| Ferring Pharmaceuticals Inc. | 1 | $16 |
Products named: PROCLAIM, ORGOVYX, Nubeqa, ANKTIVA, JELMYTO, GEMTESA, ADSTILADRIN.
Industry payments across CT — which companies pay providers there.
